Aacap Official ActionPractice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia

a neurodevelopmental disorder that is associated with deficits in cognition, affect, and social functioning. Onset of the illness occurs rarely before the age of 13 years, but then increases steadily during adolescence. Accurate diagnosis and treatment require familiarity with the clinical presentation, phenomenology, and course of the disorder. Diagnostic assessment must also incorporate an understanding of the youth's developmental, social, educational, and psychological needs. Treatment strategies should focus on alleviating symptoms, reducing long-term morbidity, and preventing relapse. Associated comorbid disorders and/or biopsychosocial stressors may also need to be addressed. Intervention strategies also must be consistent with the developmental, social, and cultural aspects of the youth and his or her family. This summary provides an overview of the assessment and treatment recommendations contained in the Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia. This summary includes many of the most important points and recommendations that are in these practice guidelines. However, the treatment and assessment of children and adolescents with schizophrenia requires the consideration of many important factors that cannot be conveyed fully in a summary, and the reader is encouraged to review the entire document. Each recommendation in the executive summary is identified as falling into one of the following categories of endorsement, indicated by an abbreviation in brackets following the statement. These categories indicate the degree of importance or certainty of each recommendation. " Minimal Standards " [MS] are recommendations that are based on substantial empirical evidence (such as well-controlled, double-blind trials) or overwhelming clinical consensus or legal and regulatory requirements. Minimal standards are expected to apply more than 95% of the time, i.e., in almost all cases. When the practitioner does not follow this standard in a particular case, the medical record should indicate the reason. " Clinical Guidelines " [CG] are recommendations that are based on empirical evidence (such as open trials, case studies) and/or strong clinical consensus. Clinical guidelines apply approximately 75% of the time. These practices should always be considered by the clinician, but there are exceptions to their application. " Options " [OP] are practices that are acceptable but not required. There may be insufficient empirical evidence to support recommending these practices as minimal standards or clinical guidelines. In some cases they may be indicated, but in other cases they should be avoided. If possible, the practice parameters will explain the pros and cons of these options. " Not …

[1]  Melvin Lewis Child and Adolescent Psychiatry: A Comprehensive Textbook , 2002 .

[2]  A Labelle,et al.  Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. , 2000, Archives of general psychiatry.

[3]  J. Rapoport,et al.  Velocardiofacial syndrome in childhood-onset schizophrenia. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  Rob Nicolson,et al.  Childhood-onset schizophrenia: rare but worth studying , 1999, Biological Psychiatry.

[5]  R. Pipe,et al.  Quetiapine in adolescent psychosis. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[6]  J. McClellan,et al.  Early-onset psychotic disorders: course and outcome over a 2-year period. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[7]  P. Thyrum,et al.  Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine in adolescents with selected psychotic disorders , 1999, European Neuropsychopharmacology.

[8]  J. Rapoport,et al.  Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. , 1999, Archives of general psychiatry.

[9]  J. Rapoport,et al.  Including children and adolescents with schizophrenia in medication-free research. , 1999, The American journal of psychiatry.

[10]  J. Rapoport,et al.  Antipsychotics in children and adolescents. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[11]  A. Meyer-Lindenberg,et al.  Cognitive dysfunction in schizophrenia: a new set of tools for the assessment of cognition and drug effects , 1999, Acta psychiatrica Scandinavica. Supplementum.

[12]  S. Purdon Cognitive improvement in schizophrenia with novel antipsychotic medications , 1999, Schizophrenia Research.

[13]  J. Lieberman,et al.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. , 1999, Archives of general psychiatry.

[14]  M. Alpert,et al.  Neuroleptic malignant syndrome in children and adolescents. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[15]  S. Leucht,et al.  Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials , 1999, Schizophrenia Research.

[16]  Abraham Weizman,et al.  Use of atypical neuroleptics in child and adolescent psychiatry. , 1998, The Journal of clinical psychiatry.

[17]  R. Findling,et al.  Quetiapine for refractory schizophrenia. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[18]  J. Levitt,et al.  Preliminary study of frontal lobe 1H MR spectroscopy in childhood‐onset schizophrenia , 1998, Journal of magnetic resonance imaging : JMRI.

[19]  J N Giedd,et al.  Quantitative morphology of the cerebellum and fourth ventricle in childhood-onset schizophrenia. , 1997, The American journal of psychiatry.

[20]  J. Rapoport,et al.  Autonomic nervous system markers of psychopathology in childhood-onset schizophrenia. , 1997, Archives of general psychiatry.

[21]  J L Rapoport,et al.  Childhood-Onset Schizophrenia: Progressive Ventricular Change During Adolescence , 1997 .

[22]  P. Mundy,et al.  Subclinical hallucinations and delusions in nonpsychotic adolescents. , 1997, Journal of child psychology and psychiatry, and allied disciplines.

[23]  J. Gorman,et al.  Risperidone in adolescents with schizophrenia: an open pilot study. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[24]  S. Kumra,et al.  Case study: risperidone-induced hepatotoxicity in pediatric patients. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[25]  J. Rapoport,et al.  Pubertal development and onset of psychosis in childhood onset schizophrenia , 1997, Psychiatry Research.

[26]  R. Borison Recent Advances in the Pharmacotherapy of Schizophrenia , 1997, Harvard review of psychiatry.

[27]  B. Gallhofer,et al.  Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs , 1996, European Neuropsychopharmacology.

[28]  J. Rapoport,et al.  Childhood-onset schizophrenia: A double-blind clozapine-haloperidol comparison , 1996 .

[29]  W. Klykylo,et al.  Risperidone and tardive dyskinesia. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[30]  S. Bouchard,et al.  Long-Term Stability of Diagnosis and Symptom Dimensions in a Systematic Sample of Patients with Onset of Schizophrenia in Childhood and Early Adolescence. I: Nosology, Sex and Age of Onset , 1996, British Journal of Psychiatry.

[31]  S. Bouchard,et al.  Long-Term Stability of Diagnosis and Symptom Dimensions in a Systematic Sample of Patients with Onset of Schizophrenia in Childhood and Early Adolescence. II: Positive/Negative Distinction and Childhood Predictors of Adult Outcome , 1996, British Journal of Psychiatry.

[32]  P. Thomsen Schizophrenia with childhood and adolescent onset — a nationwide register‐based study , 1996, Acta psychiatrica Scandinavica.

[33]  J C Rajapakse,et al.  Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. , 1996, Archives of general psychiatry.

[34]  D. Guthrie,et al.  Conversational repair in schizophrenic and normal children. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  J. Cueva,et al.  RISPERIDONE IN CHILDREN WITH SCHIZOPHRENIA , 1996 .

[36]  M. Keshavan,et al.  Case study: risperidone in children and adolescents with schizophrenia. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[37]  C. Gordon,et al.  Childhood-onset schizophrenia: The severity of premorbid course , 1995, Biological Psychiatry.

[38]  P. Yang,et al.  Comparison of adult manifestations of schizophrenia with onset before and after 15 years of age , 1995, Acta psychiatrica Scandinavica.

[39]  H. Meltzer,et al.  Recent advances in the pharmacotherapy of schxzophrenia , 1994, Acta psychiatrica Scandinavica. Supplementum.

[40]  J L Rapoport,et al.  Looking for childhood-onset schizophrenia: the first 71 cases screened. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[41]  B. Rund,et al.  The Psychosis Project: outcome and cost‐effectiveness of a psychoeducational treatment programme for schizophrenic adolescents , 1994, Acta psychiatrica Scandinavica.

[42]  D. Cohen,et al.  Conceptualizing "borderline syndrome of childhood" and "childhood schizophrenia" as a developmental disorder. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[43]  J. McClellan,et al.  A follow-up study of early onset psychosis: Comparison between outcome diagnoses of schizophrenia, mood disorders, and personality disorders , 1993, Journal of autism and developmental disorders.

[44]  C A Sandman,et al.  Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. , 1993, Archives of general psychiatry.

[45]  T. Kemper,et al.  The contribution of neuropathologic studies to the understanding of autism. , 1993, Neurologic clinics.

[46]  J. Werry Child and adolescent (early onset) schizophrenia: A review in light of DSM-III-R , 1992, Journal of autism and developmental disorders.

[47]  F. Putnam,et al.  Clinical phenomenology of child and adolescent dissociative disorders. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[48]  W. H. Green,et al.  Schizophrenia with childhood onset: a phenomenological study of 38 cases. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[49]  R. Famularo,et al.  Psychiatric diagnoses of maltreated children: preliminary findings. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[50]  S. Hans,et al.  Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. , 1992, Archives of general psychiatry.

[51]  F. Volkmar,et al.  Comorbid association of autism and schizophrenia. , 1991, The American journal of psychiatry.

[52]  Joseph A. King,et al.  A prospective follow-up study of so-called borderline children. , 1991, The American journal of psychiatry.

[53]  J. McClellan,et al.  Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study. , 1991, Journal of the American Academy of Child and Adolescent Psychiatry.

[54]  G. Carlson Child and adolescent mania--diagnostic considerations. , 1990, Journal of child psychology and psychiatry, and allied disciplines.

[55]  M. Bertagnoli,et al.  A review of ECT for children and adolescents. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[56]  C. Eggers Schizo-affective psychoses in childhood: A follow-up study , 1989, Journal of autism and developmental disorders.

[57]  A. Russell,et al.  The phenomenology of schizophrenia occurring in childhood. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[58]  D. Guthrie,et al.  The Kiddie Formal Thought Disorder Rating Scale: clinical assessment, reliability, and validity. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[59]  R. Asarnow,et al.  Symptom development in childhood onset schizophrenia. , 1988, Journal of child psychology and psychiatry, and allied disciplines.

[60]  J. Asarnow,et al.  Parental communication deviance in childhood onset schizophrenia spectrum and depressive disorders. , 1988, Journal of child psychology and psychiatry, and allied disciplines.

[61]  M. D. Del Beccaro,et al.  Hallucinations in children: a follow-up study. , 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

[62]  T. Goldberg,et al.  Intellectual impairment in adolescent psychosis A controlled psychometric study , 1988, Schizophrenia Research.

[63]  J. Asarnow,et al.  Children with schizophrenia spectrum and depressive disorders: a comparative study of premorbid adjustment, onset pattern and severity of impairment. , 1988, Journal of child psychology and psychiatry, and allied disciplines.

[64]  F. Volkmar,et al.  Phenomenology and classification of the childhood psychoses , 1988, Psychological Medicine.

[65]  T. McGlashan Adolescent versus adult onset of mania. , 1988, The American journal of psychiatry.

[66]  E. Walker,et al.  Positive and negative symptoms in psychotic and other psychiatrically disturbed children. , 1987, Journal of child psychology and psychiatry, and allied disciplines.

[67]  D. Weinberger Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.

[68]  Jerry M. Lewis Expressed Emotion in Families: Its Significance for Mental Illness , 1986 .

[69]  G. Hogarty,et al.  Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion. , 1986, Archives of general psychiatry.

[70]  M. Garralda Characteristics of the psychoses of late onset in children and adolescents (a comparative study of hallucinating children). , 1985, Journal of adolescence.

[71]  M. Garralda Hallucinations in children with conduct and emotional disorders: II. The follow-up study , 1984, Psychological Medicine.

[72]  M. Garralda Hallucinations in children with conduct and emotional disorders: I. The clinical phenomena , 1984, Psychological Medicine.

[73]  A. Loranger Sex difference in age at onset of schizophrenia , 1984 .

[74]  L. Erlenmeyer‐Kimling,et al.  A comparison of schizophrenic and autistic children. , 1984, Journal of the American Academy of Child Psychiatry.

[75]  A. Loranger Sex difference in age at onset of schizophrenia. , 1984, Archives of general psychiatry.

[76]  P. Joyce Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia , 1984, Psychological Medicine.

[77]  J. Beitchman Childhood schizophrenia: a review and comparison with adult onset schizophrenia. , 1983, Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa.

[78]  T. Pezzot-Pearce,et al.  Childhood schizophrenia: present but not accounted for. , 1982, The American journal of psychiatry.

[79]  C. Eggers Course and prognosis of childhood schizophrenia , 1978, Journal of autism and childhood schizophrenia.

[80]  M. Rutter Childhood schizophrenia reconsidered , 1972, Journal of autism and childhood schizophrenia.

[81]  R. Liberman,et al.  Psychosocial skills training for schizophrenia: lessons from the laboratory. , 2000, Schizophrenia bulletin.

[82]  J. Rapoport,et al.  "Multidimensionally impaired disorder": is it a variant of very early-onset schizophrenia? , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[83]  J L Rapoport,et al.  Research update: childhood-onset schizophrenia: implications of clinical and neurobiological research. , 1998, Journal of child psychology and psychiatry, and allied disciplines.

[84]  C. Eggers,et al.  The long-term course of childhood-onset schizophrenia: a 42-year followup. , 1997, Schizophrenia bulletin.

[85]  J. Jesberger,et al.  Cognitive impairment in adolescents with schizophrenia. , 1997, The American journal of psychiatry.

[86]  H. Meltzer,et al.  Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. , 1997, The American journal of psychiatry.

[87]  J. Rapoport,et al.  Childhood-onset schizophrenia: biological markers in relation to clinical characteristics. , 1997, The American journal of psychiatry.

[88]  Julie Kreyenbuhl,et al.  Practice guideline for the treatment of patients with schizophrenia , 1997 .

[89]  S. Schulz,et al.  Risperidone in the treatment of children and adolescents with schizophrenia: a retrospective study. , 1996, Journal of child and adolescent psychopharmacology.

[90]  R. Edleman Risperidone side effects. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[91]  N. Carrey,et al.  Risperidone Effects in Treatment-Resistant Adolescents: Preliminary Case Reports , 1995 .

[92]  M. Mandoki Risperidone Treatment of Children and Adolescents: Increased Risk of Extrapyramidal Side Effects? , 1995 .

[93]  C. Baltaxe,et al.  Speech and language disorders in children and adolescents with schizophrenia. , 1995, Schizophrenia bulletin.

[94]  A. Pumariega,et al.  Influence of race on diagnosis in adolescent psychiatric inpatients. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[95]  M. Campbell,et al.  Schizophrenia in hospitalized adolescents: clinical diagnosis, DSM-III-R, DSM-IV, and ICD-10 criteria. , 1995, Psychopharmacology bulletin.

[96]  D. Hommer,et al.  Childhood-onset schizophrenia: an NIMH study in progress. , 1994, Schizophrenia bulletin.

[97]  E. Granholm,et al.  Cognitive/neuropsychological studies of children with a schizophrenic disorder. , 1994, Schizophrenia bulletin.

[98]  R. Caplan Communication deficits in childhood schizophrenia spectrum disorders. , 1994, Schizophrenia bulletin.

[99]  J. McClellan,et al.  Predicting outcome in child and adolescent (early onset) schizophrenia and bipolar disorder. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[100]  V. Kafantaris,et al.  Haloperidol in schizophrenic children: early findings from a study in progress. , 1992, Psychopharmacology bulletin.

[101]  H. Remschmidt,et al.  The Concept of Positive and Negative Schizophrenia in Child and Adolescent Psychiatry , 1991 .

[102]  J. Marks Substances of Abuse , 1986 .

[103]  W. D. Erickson,et al.  Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents. , 1984, The American journal of psychiatry.

[104]  D. Gallant,et al.  A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients. , 1976, Current therapeutic research, clinical and experimental.

[105]  L. Perron THE PSYCHOSES OF CHILDHOOD. , 1964, The Canadian nurse.